Developer docs
API playgroundTry for free, no card

Search company profiles

Seed Health

Full company profile

uuid00003dj

Namestring
Seed Health
Legal namestring
Seed Health, Inc.
Websiteurl
seedhealth.com
Company typeenum
Private
Founded yearint
2016
Descriptiontext

Seed Health, Inc. is a Delaware-incorporated microbiome science company founded in 2016 that develops, markets, and sells clinically studied probiotic and synbiotic supplements for consumer digestive and broader wellness use. The company's core offering is the DS-01® Daily Synbiotic, a 24-strain synbiotic delivered via its proprietary ViaCap® dual-capsule technology that protects live probiotic strains through stomach acid and releases them in the colon. The portfolio extends to DM-02™ Daily Multivitamin, AM-02™ Energy + Focus, PM-02™ Sleep + Restore, and (as of May 2024) VS-01 for vaginal microbiome health, available individually or in bundles such as the Daily Essentials Duo.

The company monetizes primarily through a direct-to-consumer monthly subscription model priced at $34.99–$49.99 per SKU, augmented by retail distribution in all Target stores and all 450 Sprouts Farmers Market locations (both from September 2024) and Amazon marketplace. It claims the position of the #1 digestive health probiotic in the United States with over 1 million documented customer transformations and has reported over 500% revenue growth in the three years to 2025. A 350-participant, 40-state randomized controlled trial on DS-01 supports efficacy claims, and the company operates a SeedLabs research division focused on environmental microbiome applications alongside its human-health business.

Seed Health employs 51–100 people, is co-led by founders including co-CEO Ara Katz, and in May 2026 appointed its first Chief Marketing Officer to support a transition from premium DTC niche to mass-market scale. The company raised approximately $40 million in Series A financing in 2021 (Founders Fund, Artis Ventures, The Craftory, and others) and acquired Auggi in February 2021 to bolster in-house R&D capabilities.

Short descriptiontext

Seed Health is a microbiome science company that develops and sells clinically studied probiotic supplements, led by its DS-01 Daily Synbiotic with proprietary ViaCap delivery, sold via DTC subscription, Amazon, and national retail to health-conscious US consumers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersVenice, United States
HQ citystring
Venice
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
probiotic supplements, synbiotic formulations, digestive health products, microbiome science, daily multivitamins
Industry2 codes
1Probiotics & Digestive Health Supplements
CodeCRADAGAFPrimaryYes
2Probiotics (Strains, Spore-Formers, Synbiotic Components)
CodeAFAJAKAEPrimaryNo
NAICS code1 code
  • Biological Product (except Diagnostic) Manufacturing325414
SIC code2 codes
  • Biological Products, (No Disgnostic Substances)2836
  • Pharmaceutical Preparations2834
Product category
Probiotic and Synbiotic Dietary Supplements
Social media profiles3 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model2 records
1Product Sales - Subscription
TypeSubscription Recurring
Description

Seed Health generates revenue primarily through direct-to-consumer product sales via subscription model. Products include DS-01 Daily Synbiotic ($49.99/month), DM-02 Daily Multivitamin ($39.99/month), AM-02 Energy + Focus ($34.99/month), and PM-02 Sleep + Restore ($34.99/month). The subscription model provides recurring revenue with monthly billing cadence.

seed.com
2Retail Distribution
TypeSubscription Recurring
Description

Revenue generated through retail partnerships with Target and Sprouts Farmers Market where products are sold through physical retail locations alongside e-commerce channels, expanding revenue streams beyond direct subscription model.

uschamber.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Personnel, Marketing or Sales, Technology or R&D, Operations
Pricing details5 tiers
1DS-01 Daily Synbiotic - Core probiotic product
ModelSubscriptionBilling cadenceMonthly
Notes

Starting at $49.99 per month for DS-01 Daily Synbiotic with ViaCap technology and 24 probiotic strains

seed.com
2DM-02 Daily Multivitamin
ModelSubscriptionBilling cadenceMonthly
Notes

Starting at $39.99 per month for DM-02 Daily Multivitamin formulation

seed.com
3AM-02 Energy + Focus
ModelSubscriptionBilling cadenceMonthly
Notes

Starting at $34.99 per month for AM-02 Energy + Focus supplement

seed.com
4PM-02 Sleep + Restore
ModelSubscriptionBilling cadenceMonthly
Notes

Starting at $34.99 per month for PM-02 Sleep + Restore supplement

seed.com
5Daily Essentials Duo Bundle
ModelSubscriptionBilling cadenceMonthly
Notes

Bundle combining DS-01 and DM-02 with 25% savings off regular individual prices

seed.com
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 6 records shown
1DS-01 Daily Synbiotic
Description

The company's flagship synbiotic product; clinically studied 24-strain probiotic with ViaCap technology; positioned as the #1 digestive health probiotic in the United States.

seed.com
+5 more records
Core offering1 text field

Seed Health develops, manufactures, and sells clinically studied probiotic and synbiotic dietary supplements built around its proprietary ViaCap dual-capsule delivery technology. The flagship DS-01 Daily Synbiotic contains 24 live probiotic strains and is supported by a 350-participant randomized clinical trial. The product portfolio includes DM-02 Daily Multivitamin, AM-02 Energy + Focus, PM-02 Sleep + Restore, VS-01 for vaginal microbiome health, and bundled offerings.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Reduces bloating, gas, and abdominal discomfort while improving bowel regularity and digestive quality of life in healthy adults within one week
+3 more records
Product overview1 text field

Seed Health is a microbiome science company offering a portfolio of scientifically formulated supplements built around its core DS-01® Daily Synbiotic. The product line includes the flagship DS-01® Daily Synbiotic (the #1 digestive health probiotic in the US), paired with DM-02™ Daily Multivitamin, and add-on supplements AM-02™ Energy + Focus and PM-02™ Sleep + Restore. Products are available individually or bundled as the Daily Essentials Duo. The company also launched VS-01 for vaginal microbiome health in 2024. All products feature ViaCap® technology for enhanced probiotic delivery through digestion.

Product and service6 records
1DS-01 Daily Synbiotic
CategoryProbiotic / Synbiotic Supplement
Description

Flagship 24-strain daily synbiotic probiotic supplement clinically studied in a 350-participant randomized trial to reduce bloating, gas, and abdominal discomfort while improving bowel regularity. Features ViaCap dual-capsule delivery technology. Positioned as the #1 digestive health probiotic in the United States.

2DM-02 Daily Multivitamin
CategoryMultivitamin Supplement
Description

Daily multivitamin supplement designed to cover nutrient gaps and support overall nutritional health, designed to pair with DS-01 in the Daily Essentials Duo bundle.

3AM-02 Energy + Focus
CategoryDietary Supplement
Description

Energy and focus supplement designed to support sustained energy levels and cognitive function as part of Seed's daily routine portfolio.

4PM-02 Sleep + Restore
CategoryDietary Supplement
Description

Sleep and restoration supplement designed to support healthy sleep patterns and overnight recovery as part of Seed's daily routine portfolio.

5VS-01 Vaginal Microbiome Health Supplement
CategoryProbiotic / Microbiome Supplement
Description

Supplement launched in May 2024 for vaginal microbiome health, expanding Seed's portfolio beyond its flagship digestive synbiotic into personalized microbiome applications.

6Daily Essentials Duo
CategoryProduct Bundle
Description

Bundle combining DS-01 Daily Synbiotic and DM-02 Daily Multivitamin at a 25% discount, offering comprehensive nutrition and digestive health support.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-04-21
Description

Seed Health and The Two Frontiers Project launched The Resilient Soils Project, a community science initiative investigating how soil microbes adapt to environments contaminated with PFAS and other synthetic chemicals. The project invites the public to submit soil samples from contaminated sites for metagenomic sequencing to identify microbial traits that could inform biological remediation methods. Findings will be added to 2FP's open-access Living Database for global researchers.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

One of the leading clinically-studied probiotic brands in US mass retail; directly competes with DS-01 in the digestive-health probiotic segment and sells through the same Target/Sprouts-class channels.

TypeDirect peer
Description

DTC subscription supplement brand built on clinically validated ingredients and science-led storytelling; competes head-to-head with Seed in the premium multivitamin/synbiotic category for the same health-conscious consumer.

TypeBroad incumbent
Description

Global incumbent in probiotic functional beverages with deep brand equity and grocery distribution; relevant comparable for category maturity and the ceiling on probiotics consumer brand scale.

TypeEmerging player
Description

Science-led gut health and personalized nutrition company combining microbiome testing with food/supplement recommendations; overlaps with Seed on gut-health science credibility and consumer education approach.

TypeDirect peer
Description

DTC wellness supplements brand targeting the same female, health-conscious consumer with daily supplements, often marketed through influencer/credentialing channels similar to Seed's program.

6Care/of
TypeDirect peer
Description

Personalized DTC vitamin/supplement subscription using a digital quiz and monthly packs; directly comparable business model and target customer to Seed's quiz-driven, subscription-based wellness positioning.

TypeDirect peer
Description

Mass-market vitamins and probiotics brand sold through Target and grocery; competes with Seed on shelf space in the same VMS category and on price-conscious younger demographics.

TypeDirect peer
Description

Single-subscription daily greens/nutrition powder positioned around gut health and comprehensive daily nutrition; overlaps with Seed's DS-01/DM-02 bundle on the 'daily essentials' subscription occasion.

TypeDirect peer
Description

Procter & Gamble's digestive-health probiotic brand with deep retail penetration and strong clinician recommendations; competes with DS-01 for the same bloating/digestive health use case across drug and grocery channels.

TypeEmerging player
Description

Microbiome-focused DTC probiotic brand with clinical claims around glucose control and metabolic health; comparable to Seed in science-led positioning and clinical-trial-backed marketing, though narrower in use case.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds8 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors21 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment1 record

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Seed Health

Probiotic and Synbiotic Dietary Supplementsseedhealth.com

Seed Health is a microbiome science company that develops and sells clinically studied probiotic supplements, led by its DS-01 Daily Synbiotic with proprietary ViaCap delivery, sold via DTC subscription, Amazon, and national retail to health-conscious US consumers.

What Seed Health does

Seed Health, Inc. is a Delaware-incorporated microbiome science company founded in 2016 that develops, markets, and sells clinically studied probiotic and synbiotic supplements for consumer digestive and broader wellness use. The company's core offering is the DS-01® Daily Synbiotic, a 24-strain synbiotic delivered via its proprietary ViaCap® dual-capsule technology that protects live probiotic strains through stomach acid and releases them in the colon. The portfolio extends to DM-02™ Daily Multivitamin, AM-02™ Energy + Focus, PM-02™ Sleep + Restore, and (as of May 2024) VS-01 for vaginal microbiome health, available individually or in bundles such as the Daily Essentials Duo.

The company monetizes primarily through a direct-to-consumer monthly subscription model priced at $34.99–$49.99 per SKU, augmented by retail distribution in all Target stores and all 450 Sprouts Farmers Market locations (both from September 2024) and Amazon marketplace. It claims the position of the #1 digestive health probiotic in the United States with over 1 million documented customer transformations and has reported over 500% revenue growth in the three years to 2025. A 350-participant, 40-state randomized controlled trial on DS-01 supports efficacy claims, and the company operates a SeedLabs research division focused on environmental microbiome applications alongside its human-health business.

Seed Health employs 51–100 people, is co-led by founders including co-CEO Ara Katz, and in May 2026 appointed its first Chief Marketing Officer to support a transition from premium DTC niche to mass-market scale. The company raised approximately $40 million in Series A financing in 2021 (Founders Fund, Artis Ventures, The Craftory, and others) and acquired Auggi in February 2021 to bolster in-house R&D capabilities.

Seed Health firmographics

Firmographics
Name
Seed Health
Legal name
Seed Health, Inc.
Website
https://seedhealth.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
51–100 employees
Short description
Seed Health is a microbiome science company that develops and sells clinically studied probiotic supplements, led by its DS-01 Daily Synbiotic with proprietary ViaCap delivery, sold via DTC subscription, Amazon, and national retail to health-conscious US consumers.
Ownership category
akta.pro rank

Seed Health industry classification

Industry
Product category
Probiotic and Synbiotic Dietary Supplements
NAICS
Biological Product (except Diagnostic) Manufacturing (325414)
SIC
Biological Products, (No Disgnostic Substances) (2836), Pharmaceutical Preparations (2834)
akta.pro primary industry
Probiotics & Digestive Health Supplements (CRADAGAF)
akta.pro secondary industry
Probiotics (Strains, Spore-Formers, Synbiotic Components) (AFAJAKAE)

Keywords

  • Probiotic supplements
  • Synbiotic formulations
  • Digestive health products
  • Microbiome science
  • Daily multivitamins

Where Seed Health is headquartered

Location

Headquarters

HQ city
Venice
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Seed Health business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Marketing or Sales, Technology or R&D, Operations

Revenue model

  1. Product Sales - Subscription: Seed Health generates revenue primarily through direct-to-consumer product sales via subscription model. Products include DS-01 Daily Synbiotic ($49.99/month), DM-02 Daily Multivitamin ($39.99/month), AM-02 Energy + Focus ($34.99/month), and PM-02 Sleep + Restore ($34.99/month). The subscription model provides recurring revenue with monthly billing cadence.
  2. Retail Distribution: Revenue generated through retail partnerships with Target and Sprouts Farmers Market where products are sold through physical retail locations alongside e-commerce channels, expanding revenue streams beyond direct subscription model.

Pricing tiers

ModelBillingPrice
SubscriptionMonthlyDS-01 Daily Synbiotic - Core probiotic product
SubscriptionMonthlyDM-02 Daily Multivitamin
SubscriptionMonthlyAM-02 Energy + Focus
SubscriptionMonthlyPM-02 Sleep + Restore
SubscriptionMonthlyDaily Essentials Duo Bundle

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

Seed Health product offering

Product offering

Core offering

Seed Health develops, manufactures, and sells clinically studied probiotic and synbiotic dietary supplements built around its proprietary ViaCap dual-capsule delivery technology. The flagship DS-01 Daily Synbiotic contains 24 live probiotic strains and is supported by a 350-participant randomized clinical trial. The product portfolio includes DM-02 Daily Multivitamin, AM-02 Energy + Focus, PM-02 Sleep + Restore, VS-01 for vaginal microbiome health, and bundled offerings.

Product overview

Seed Health is a microbiome science company offering a portfolio of scientifically formulated supplements built around its core DS-01® Daily Synbiotic. The product line includes the flagship DS-01® Daily Synbiotic (the #1 digestive health probiotic in the US), paired with DM-02™ Daily Multivitamin, and add-on supplements AM-02™ Energy + Focus and PM-02™ Sleep + Restore. Products are available individually or bundled as the Daily Essentials Duo. The company also launched VS-01 for vaginal microbiome health in 2024. All products feature ViaCap® technology for enhanced probiotic delivery through digestion.

Differentiator

Problem solved

Functional benefit

Brands

  • DS-01 Daily Synbiotic: The company's flagship synbiotic product; clinically studied 24-strain probiotic with ViaCap technology; positioned as the #1 digestive health probiotic in the United States.
  • DM-02 Daily Multivitamin
  • AM-02 Energy + Focus
  • PM-02 Sleep + Restore
  • VS-01
  • SeedLabs

Products and services

  • DS-01 Daily Synbiotic Flagship 24-strain daily synbiotic probiotic supplement clinically studied in a 350-participant randomized trial to reduce bloating, gas, and abdominal discomfort while improving bowel regularity. Features ViaCap dual-capsule delivery technology. Positioned as the #1 digestive health probiotic in the United States.
  • DM-02 Daily Multivitamin Daily multivitamin supplement designed to cover nutrient gaps and support overall nutritional health, designed to pair with DS-01 in the Daily Essentials Duo bundle.
  • AM-02 Energy + Focus Energy and focus supplement designed to support sustained energy levels and cognitive function as part of Seed's daily routine portfolio.
  • PM-02 Sleep + Restore Sleep and restoration supplement designed to support healthy sleep patterns and overnight recovery as part of Seed's daily routine portfolio.
  • VS-01 Vaginal Microbiome Health Supplement Supplement launched in May 2024 for vaginal microbiome health, expanding Seed's portfolio beyond its flagship digestive synbiotic into personalized microbiome applications.
  • Daily Essentials Duo Bundle combining DS-01 Daily Synbiotic and DM-02 Daily Multivitamin at a 25% discount, offering comprehensive nutrition and digestive health support.

Quantifiable outcome

  • Reduces bloating, gas, and abdominal discomfort while improving bowel regularity and digestive quality of life in healthy adults within one week
  • +3 more outcomes

Companies that use Seed Health

Customer profile

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Seed Health technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Seed Health partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • The Two Frontiers Project (2FP)coreStrategic or Co-development Partner · 21 April 2026Seed Health and The Two Frontiers Project launched The Resilient Soils Project, a community science initiative investigating how soil microbes adapt to environments contaminated with PFAS and other synthetic chemicals. The project invites the public to submit soil samples from contaminated sites for metagenomic sequencing to identify microbial traits that could inform biological remediation methods. Findings will be added to 2FP's open-access Living Database for global researchers.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Seed Health competitors and assessment

Company assessment

Direct peers

  • Culturelle: One of the leading clinically-studied probiotic brands in US mass retail; directly competes with DS-01 in the digestive-health probiotic segment and sells through the same Target/Sprouts-class channels.
  • Ritual: DTC subscription supplement brand built on clinically validated ingredients and science-led storytelling; competes head-to-head with Seed in the premium multivitamin/synbiotic category for the same health-conscious consumer.
  • Hum Nutrition: DTC wellness supplements brand targeting the same female, health-conscious consumer with daily supplements, often marketed through influencer/credentialing channels similar to Seed's program.
  • Care/of: Personalized DTC vitamin/supplement subscription using a digital quiz and monthly packs; directly comparable business model and target customer to Seed's quiz-driven, subscription-based wellness positioning.
  • Olly: Mass-market vitamins and probiotics brand sold through Target and grocery; competes with Seed on shelf space in the same VMS category and on price-conscious younger demographics.
  • AG1 (Athletic Greens): Single-subscription daily greens/nutrition powder positioned around gut health and comprehensive daily nutrition; overlaps with Seed's DS-01/DM-02 bundle on the 'daily essentials' subscription occasion.
  • Align Probiotic: Procter & Gamble's digestive-health probiotic brand with deep retail penetration and strong clinician recommendations; competes with DS-01 for the same bloating/digestive health use case across drug and grocery channels.

Broad incumbents

  • Yakult: Global incumbent in probiotic functional beverages with deep brand equity and grocery distribution; relevant comparable for category maturity and the ceiling on probiotics consumer brand scale.

Emerging players

  • ZOE: Science-led gut health and personalized nutrition company combining microbiome testing with food/supplement recommendations; overlaps with Seed on gut-health science credibility and consumer education approach.
  • Pendulum: Microbiome-focused DTC probiotic brand with clinical claims around glucose control and metabolic health; comparable to Seed in science-led positioning and clinical-trial-backed marketing, though narrower in use case.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Seed Health social profiles

Digital presence

Seed Health financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Seed Health leadership team

Management profile

Number of profiles

Profiles9 records

Seed Health funding detail

Funding detail

Funding overview

Funding rounds8 records

Investors21 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Seed Health M&A and investment

M&A and investment

M&A1 record

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Seed Health

What does Seed Health do?

Seed Health develops, manufactures, and sells clinically studied probiotic and synbiotic dietary supplements built around its proprietary ViaCap dual-capsule delivery technology. The flagship DS-01 Daily Synbiotic contains 24 live probiotic strains and is supported by a 350-participant randomized clinical trial. The product portfolio includes DM-02 Daily Multivitamin, AM-02 Energy + Focus, PM-02 Sleep + Restore, VS-01 for vaginal microbiome health, and bundled offerings.

Is Seed Health a public or private company?

Seed Health is a private company. It is classified as venture growth investor backed and is currently operating.

When was Seed Health founded?

Seed Health was founded in 2016. It employs 51 to 100 people.

Where is Seed Health based?

Seed Health is headquartered in Venice, United States, in the North America region.

How does Seed Health make money?

Two revenue lines are on record. Product Sales - Subscription is the primary driver. The others are retail Distribution.

Who are Seed Health's main competitors?

Direct peers on record are Culturelle, Ritual, Hum Nutrition, Care/of, Olly, AG1 (Athletic Greens) and Align Probiotic. Yakult is listed as a broad incumbent. Emerging players are ZOE and Pendulum.

Does Seed Health have an API?

No public API is recorded for Seed Health.

What industry is Seed Health in?

Seed Health's product category is Probiotic and Synbiotic Dietary Supplements. Its primary akta.pro industry code is CRADAGAF, Probiotics & Digestive Health Supplements, with a secondary code of AFAJAKAE, Probiotics (Strains, Spore-Formers, Synbiotic Components). Its NAICS code is 325414 and its SIC code is 2836.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
ForbesHow To Raise Capital When Your Biotech Has A Consumer BusinessAbdelahhad Barbour advises biotech founders to align consumer and scientific assets around a shared technology, as seen in Seed Health and Pendulum. He warns that consumer revenue alone does not reduce capital dependence if unit economics fail, citing 23andMe's decline. Financing should target inflection points, not just dilution.AijournNew Data Show Seed’s Co-Biotics Increase Bioactive Vitamin B3, Gut-Brain Metabolites, and Sleep-Related Tryptophan Through the MicrobiomeMicrobiome science company Seed Health presented three preclinical studies at NUTRITION 2026 demonstrating that its Co-Biotic supplement formulations—DM-02, AM-02, and PM-02—can modulate the gut microbiome through distinct pathways relevant to nutrient metabolism, gut-brain signaling, and sleep biology. The studies, conducted using an ex vivo gastrointestinal model with SIFR® technology, showed significant increases in bioactive vitamin B3 (10-fold versus nicotinic acid alone), short-chain fatty acids acetate and butyrate (11–20% increases), and colonic tryptophan availability (48%). The findings position Co-Biotics as a new category of supplementation designed for both human and microbial biology, representing a mechanistic rather than clinical validation of the products.PR NewswireNew Data Show Seed's Co-Biotics Increase Bioactive Vitamin B3, Gut-Brain Metabolites, and Sleep-Related Tryptophan Through the MicrobiomeSeed Health presented three preclinical studies at NUTRITION 2026 demonstrating that its Co-Biotic supplement formulations (DM-02, AM-02, and PM-02) engage distinct microbiome-mediated pathways for nutrient metabolism, gut-brain signaling, and sleep-related biology. Using an ex vivo gastrointestinal model with SIFR technology, researchers found that DM-02 increased bioactive vitamin B3 approximately 10-fold versus nicotinic acid alone, AM-02 increased acetate by 12% and butyrate by 20%, and PM-02 increased colonic tryptophan availability by 48%. The company stated the findings establish a mechanistic foundation for Co-Biotics as a new category of daily supplementation designed for both human and microbial biology.PR NewswireSeed Health Appoints Anisha Raghavan as First-Ever Chief Marketing Officer to Lead Next Chapter of Brand GrowthSeed Health, a microbiome science company, announced the appointment of Anisha Raghavan as its first chief marketing officer, effective immediately. Raghavan brings over two decades of experience building and scaling consumer brands at Unilever, PepsiCo, and most recently Heyday Skincare, where she will lead the company's global marketing organization overseeing brand, growth, creative, and commercial strategy. The appointment comes as Seed Health, which holds the position of leading brand in gut health supplements and maker of the number one digestive health probiotic in the United States, continues strong profitable growth across direct-to-consumer, Amazon, and retail channels.Business InsiderMicrobiome startup Seed Health hires its first CMO to scale from cult favorite to household nameSeed Health, a microbiome science company founded in 2016, has appointed consumer marketing veteran Anisha Raghavan as its first-ever chief marketing officer to lead its next stage of growth. Raghavan plans to expand retail presence and brand awareness as the company, backed by investors including Founders Fund and celebrities, looks to scale from a premium niche to mass market while growing revenue by over 500% in three years. Her strategy includes unexpected partnerships, interactive elements, and influencer collaborations through a science-based credentialing program.PR NewswireSeed Health and The Two Frontiers Project Launch Initiative to Explore Microbial Solutions to "Forever Chemicals"Seed Health and The Two Frontiers Project (2FP) launched The Resilient Soils Project, a community science initiative investigating how soil microbes adapt to environments contaminated with PFAS and other synthetic chemicals. The project invites the public to submit soil samples from contaminated sites for metagenomic sequencing to identify microbial traits that could inform biological remediation methods. Findings will be added to 2FP's open-access Living Database for global researchers studying microbial solutions to environmental contamination.openPR.comIs the Gut Microbiota Supplement Market the Next Big Opportunity in Functional Nutrition by 2033?DataM Intelligence released a market research report projecting the Global Gut Microbiota Supplement Market to grow at a high CAGR between 2026 and 2033, driven by increasing consumer demand for functional nutrition and precision microbiome solutions. Multiple companies announced product launches, R&D investments, and capacity expansions in 2025-2026, including Nestlé Health Science, Seed Health, ADM, Pendulum Therapeutics in the United States, and Yakult Honsha, Meiji Holdings, Morinaga Milk Industry, and Kirin Holdings in Japan. The report segments the market by ingredient, form, end-user, and distribution channel, identifying growth opportunities across North America, Asia-Pacific, and Europe.BoldcapitalpartnersNew Clinical Trial Shows Seed's DS-01® Reduces Bloating, Improves Regularity, and Enhances Digestive Quality of LifeMicrobiome science company Seed Health announced publication of clinical trial findings in the journal Nutrients, showing that its DS-01® Daily Synbiotic significantly reduces bloating, gas, and abdominal discomfort while improving bowel regularity and digestive quality of life in healthy adults. The randomized, placebo-controlled trial enrolled 350 participants across 40 U.S. states over six weeks and represents the largest such probiotic or synbiotic clinical trial evaluating bloating in a non-patient population. The company highlighted the findings as reinforcing DS-01®'s position as the top-selling digestive health probiotic in the United States.PR NewswireNew Clinical Trial Shows Seed's DS-01® Reduces Bloating, Improves Regularity, and Enhances Digestive Quality of LifeMicrobiome science company Seed Health announced publication of clinical trial findings in Nutrients demonstrating that its DS-01® Daily Synbiotic significantly reduces bloating, gas, and abdominal discomfort while improving bowel regularity and digestive quality of life in otherwise healthy adults. The randomized, double-blind, placebo-controlled trial enrolled 350 participants across 40 U.S. states over six weeks, making it the largest such trial evaluating bloating in a non-patient population. The findings reinforce DS-01®'s position as the #1 digestive health probiotic in the United States.EIN PresswireSynbiotics Market Growth Accelerates to USD 3.36 Billion by 2032 Demand for Gut Microbiota & Digestive Health SolutionsThe Global Synbiotics Market is projected to grow from USD 1.90 billion in 2024 to USD 3.36 billion by 2032, registering a CAGR of 7.4% during 2025–2032, driven by rising demand for gut health supplements, functional foods, and nutraceutical innovations. Key recent developments include SynBiotic SE securing a €2.4 million strategic investment from IRIS Capital in April 2025 and Seed Health, Inc. launching its DS-01 Daily Synbiotic across Sprouts Farmers Market stores nationwide in June 2025. Market challenges include low shelf-life of probiotic formulations, high production costs, and limited consumer awareness in emerging Asia-Pacific regions.